These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 20584252)

  • 21. Clinical efficacy of a 308 nm excimer laser for treatment of psoriasis vulgaris.
    He YL; Zhang XY; Dong J; Xu JZ; Wang J
    Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):238-41. PubMed ID: 17986060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.
    Kanwar AJ; Dogra S; Parsad D; Kumar B
    Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo.
    Lo YH; Cheng GS; Huang CC; Chang WY; Wu CS
    J Dermatol; 2010 Feb; 37(2):125-9. PubMed ID: 20175845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of split-skin grafting in combination with excimer laser for stable vitiligo.
    Al-Mutairi N; Manchanda Y; Al-Doukhi A; Al-Haddad A
    Dermatol Surg; 2010 Apr; 36(4):499-505. PubMed ID: 20180833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pimecrolimus cream in repigmentation of vitiligo.
    Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
    Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
    Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
    Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
    Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
    Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
    J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions.
    Wu CS; Hu SC; Lan CC; Chen GS; Chuo WH; Yu HS
    Kaohsiung J Med Sci; 2008 Apr; 24(4):180-9. PubMed ID: 18424354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of excimer laser on vitiligo treatment in comparison with a combination therapy of Excimer laser and tacrolimus in an Iranian population.
    Matin M; Latifi S; Zoufan N; Koushki D; Mirjafari Daryasari SA; Rahdari F
    J Cosmet Laser Ther; 2014 Oct; 16(5):241-5. PubMed ID: 25046236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
    Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
    Fai D; Cassano N; Vena GA
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the 308-nm excimer laser with the 308-nm excimer lamp in the treatment of vitiligo--a randomized bilateral comparison study.
    Shi Q; Li K; Fu J; Wang Y; Ma C; Li Q; Li C; Gao T
    Photodermatol Photoimmunol Photomed; 2013 Feb; 29(1):27-33. PubMed ID: 23281694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
    van Geel N; Ongenae K; De Mil M; Haeghen YV; Vervaet C; Naeyaert JM
    Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of vitiligo with 308-nm excimer laser: our experience from a 2-year follow-up of 979 Chinese patients.
    Fa Y; Lin Y; Chi XJ; Shi WH; Wang JL; Guo X; Geng JH; Liu HX; Zhang FR
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):337-340. PubMed ID: 27538097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study between excimer light and topical antioxidant versus excimer light alone for treatment of vitiligo.
    Soliman M; Samy NA; Abo Eittah M; Hegazy M
    J Cosmet Laser Ther; 2016; 18(1):7-11. PubMed ID: 26052813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.
    Hamzavi I; Jain H; McLean D; Shapiro J; Zeng H; Lui H
    Arch Dermatol; 2004 Jun; 140(6):677-83. PubMed ID: 15210457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
    Hartmann A; Bröcker EB; Hamm H
    Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo.
    Kapoor R; Phiske MM; Jerajani HR
    Br J Dermatol; 2009 Apr; 160(4):861-3. PubMed ID: 19014395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.